Evidence map›Paper›PMID 35027453›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Intestinal commensal microbiota and cytokines regulate Fut2

Mariko Kamioka, Yoshiyuki Goto, Kiminori Nakamura, Yuki Yokoi, Rina Sugimoto, Shuya Ohira, Yosuke Kurashima, Shingo Umemoto, Shintaro Sato, Jun Kunisawa and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Necrotizing enterocolitis.Nature reviews. Disease primers · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Host-pathobiont interactions in Crohn's disease.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  16. Review
  17. Establishment of anMethodsX · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Mariko KamiokaDepartment of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.ORCID 0000-0003-4377-4850
Yoshiyuki GotoInternational Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Kiminori NakamuraDepartment of Cell Biological Science, Graduate School of Life Science, Faculty of Advanced Life Science, Hokkaido University, Hokkaido 001-0021, Japan.ORCID 0000-0002-2138-1733
Yuki YokoiDepartment of Cell Biological Science, Graduate School of Life Science, Faculty of Advanced Life Science, Hokkaido University, Hokkaido 001-0021, Japan.ORCID 0000-0002-8077-3200
Rina SugimotoDepartment of Cell Biological Science, Graduate School of Life Science, Faculty of Advanced Life Science, Hokkaido University, Hokkaido 001-0021, Japan.ORCID 0000-0002-0069-6963
Shuya OhiraDepartment of Cell Biological Science, Graduate School of Life Science, Faculty of Advanced Life Science, Hokkaido University, Hokkaido 001-0021, Japan.ORCID 0000-0003-4326-9707
Yosuke KurashimaDepartment of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Shingo UmemotoDepartment of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Shintaro SatoDepartment of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.ORCID 0000-0001-5156-3354
Jun KunisawaInternational Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Yu TakahashiFood Biochemistry Laboratory, Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.ORCID 0000-0003-3186-2925
Steven E DominoDepartment of Obstetrics and Gynecology, Cellular and Molecular Biology Program, University of Michigan Medical Center, Ann Arbor, MI 48109-5617.ORCID 0000-0002-5712-0535
Jean-Christophe RenauldLudwig Institute for Cancer Research, Université Catholique de Louvain, Brussels B-1200, Belgium.ORCID 0000-0003-1736-2131
Susumu NakaeGraduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima 739-8528, Japan.
Yoichiro IwakuraCenter for Experimental Animal Models, Institute for Biomedical Sciences, Tokyo University of Science, Chiba 278-0022, Japan.ORCID 0000-0002-9934-5775
Peter B ErnstDepartment of Medicine, School of Medicine and Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), University of California, San Diego, CA 92093.
Tokiyoshi AyabeDepartment of Cell Biological Science, Graduate School of Life Science, Faculty of Advanced Life Science, Hokkaido University, Hokkaido 001-0021, Japan.ORCID 0000-0002-8631-5593
Hiroshi KiyonoDepartment of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; kiyono@ims.u-tokyo.ac.jp.ORCID 0000-0001-7307-4658
Hokkaido University · JPChiba University · JPHiroshima University · JPLudwig Cancer Research · BENational Institute of Biomedical Innovation, Health and Nutrition · JPOita University · JPOsaka City University · JPThe University of Tokyo · JPTokyo University of Science · JPUniversity of California San Diego · USUniversity of Michigan · US

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LARS ECKMANN, Bernd G. Schnabl · 2019 to 2026
$10.8M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
The Role of the Adenosine Receptor in Th Cell Development and FunctionR01AI079145 · NIAID · UNIVERSITY OF VIRGINIA · PI ERNST, PETER B. · 2010 to 2022
$4.7M
The Role of Adenosine Receptors in Th Cell Development and FunctionR56AI079145 · NIAID · UNIVERSITY OF VIRGINIA · PI ERNST, PETER B. · 2008 to 2008
$378k
NIAID NIH HHS R01 AI079145NIAID NIH HHS R56 AI079145NIDDK NIH HHS P30 DK120515NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Paneth cells are intestinal epithelial cells that release antimicrobial peptides, such as α-defensin as part of host defense. Together with mesenchymal cells, Paneth cells provide niche factors for epithelial stem cell homeostasis. Here, we report two subtypes of murine Paneth cells, differentiated by their production and utilization of fucosyltransferase 2 (Fut2), which regulates α(1,2)fucosylation to create cohabitation niches for commensal bacteria and prevent invasion of the intestine by pathogenic bacteria. The majority of Fut2

Indexed as

alpha-DefensinsAnimalsCytokinesFucosyltransferasesGalactoside 2-alpha-L-fucosyltransferaseGastrointestinal MicrobiomeIleumInterleukin-17Interleukin-22InterleukinsMicePaneth CellsSymbiosisalpha-DefensinsCytokinesFucosyltransferasesGalactoside 2-alpha-L-fucosyltransferaseIl17a protein, mouseInterleukin-17Interleukin-22Interleukinsfucosyltransferase 2IL-17aIL-22Paneth cellα-defensin

Identifiers

PMID35027453
PMCPMC8784097
OpenAlexW4205180878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.